Portola Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018
02 Mai 2018 - 3:33PM
Portola Pharmaceuticals, Inc.® (NASDAQ:PTLA) announced today that
it will host a webcast and conference call to discuss the Company’s
financial results for the quarter ended March 31, 2018, and provide
a general business overview on Wednesday, May 9, 2018,
at 4:30 p.m. ET (1:30 p.m. PT).
Conference Call DetailsThe live
conference call on Wednesday, May 9, 2018, at 4:30 p.m.
ET, can be accessed by phone by calling (844) 452-6828
from the United States and Canada or 1 (765)
507-2588 internationally and using the passcode 7068059. The
webcast can be accessed live on the Investor Relations section of
the Company's website at http://investors.portola.com. It will
be archived for 30 days following the call.
About Portola Pharmaceuticals,
Inc.Portola Pharmaceuticals is a biopharmaceutical company
developing product candidates that could significantly advance the
fields of thrombosis and other hematologic diseases. The Company’s
first medicine Bevyxxa® (betrixaban), an oral, once-daily Factor Xa
inhibitor, was approved by the U.S. Food and Drug Administration in
June 2017. The company is also working to advance two clinical
programs for andexanet alfa, a recombinant protein designed to
reverse the anticoagulant effect in patients treated with an oral
or injectable Factor Xa inhibitor; and cerdulatinib, a SYK/JAK
inhibitor in development to treat hematologic cancers. Portola's
partnered program is focused on developing selective SYK inhibitors
for inflammatory conditions. For more information, visit
http://www.portola.com and follow the Company on Twitter
@Portola_Pharma.
Investor Contact: Cara
MillerPortola Pharmaceuticals ir@portola.com
Media Contact:Laurie MasonsonPure
Communicationslmasonson@purecommunications.com
Portola Pharmaceuticals (NASDAQ:PTLA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Portola Pharmaceuticals (NASDAQ:PTLA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Portola Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur